July 2015 FDA Recall Drug by Teva Pharmaceuticals Usa
D-1351-2015 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on July 24, 2015 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1351-2015

Reason for Recall
Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution
Initiated
07-24-2015
Reported
09-02-2015
Quantity
6001 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Teva Pharmaceuticals USA
ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).

Batch or Lot Expiration Information

Lot# 31317857B, Exp 08/15 31317859B, Exp 12/15 31317920B, Exp 12/15 31317957B, Exp 12/15 31318136B, Exp 12/15 31318138B, Exp 12/15